全文获取类型
收费全文 | 37488篇 |
免费 | 2094篇 |
国内免费 | 224篇 |
专业分类
耳鼻咽喉 | 316篇 |
儿科学 | 537篇 |
妇产科学 | 467篇 |
基础医学 | 5123篇 |
口腔科学 | 1119篇 |
临床医学 | 2406篇 |
内科学 | 9018篇 |
皮肤病学 | 907篇 |
神经病学 | 2705篇 |
特种医学 | 1473篇 |
外科学 | 6524篇 |
综合类 | 165篇 |
一般理论 | 1篇 |
预防医学 | 1125篇 |
眼科学 | 702篇 |
药学 | 2904篇 |
中国医学 | 58篇 |
肿瘤学 | 4256篇 |
出版年
2023年 | 149篇 |
2021年 | 603篇 |
2020年 | 384篇 |
2019年 | 488篇 |
2018年 | 639篇 |
2017年 | 591篇 |
2016年 | 649篇 |
2015年 | 678篇 |
2014年 | 925篇 |
2013年 | 1141篇 |
2012年 | 1750篇 |
2011年 | 1930篇 |
2010年 | 1132篇 |
2009年 | 1007篇 |
2008年 | 1691篇 |
2007年 | 1766篇 |
2006年 | 1788篇 |
2005年 | 1870篇 |
2004年 | 1753篇 |
2003年 | 1807篇 |
2002年 | 1707篇 |
2001年 | 1350篇 |
2000年 | 1367篇 |
1999年 | 1259篇 |
1998年 | 460篇 |
1997年 | 372篇 |
1996年 | 323篇 |
1995年 | 334篇 |
1994年 | 296篇 |
1993年 | 278篇 |
1992年 | 857篇 |
1991年 | 758篇 |
1990年 | 766篇 |
1989年 | 734篇 |
1988年 | 728篇 |
1987年 | 642篇 |
1986年 | 623篇 |
1985年 | 610篇 |
1984年 | 402篇 |
1983年 | 330篇 |
1982年 | 165篇 |
1980年 | 144篇 |
1979年 | 331篇 |
1978年 | 210篇 |
1977年 | 157篇 |
1975年 | 152篇 |
1974年 | 217篇 |
1973年 | 158篇 |
1972年 | 168篇 |
1971年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 21 毫秒
1.
Harada Hideyuki Omori Shota Mori Keita Konno Masahiro Murakami Haruyasu Imagumbai Toshiyuki Fukuda Haruyuki Nakamatsu Kiyoshi Kimura Tomoki Tanabe Hiroaki Fujita Hideki Tatebe Hitoshi Fujitaka Kazunori Nishimura Yasumasa 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(6):1025-1033
International Journal of Clinical Oncology - This multi-institutional clinical trial evaluated the feasibility of intensity-modulated radiotherapy (IMRT) for patients with locally advanced... 相似文献
2.
3.
Kazuko Sakai Takayuki Takahama Mototsugu Shimokawa Koichi Azuma Masayuki Takeda Terufumi Kato Haruko Daga Isamu Okamoto Hiroaki Akamatsu Shunsuke Teraoka Akira Ono Tatsuo Ohira Toshihide Yokoyama Nobuyuki Yamamoto Kazuhiko Nakagawa Kazuto Nishio 《Molecular oncology》2021,15(1):126
The WJOG8815L phase II clinical study involves patients with non‐small cell lung cancer (NSCLC) that harbored the EGFR T790M mutation, which confers resistance to EGFR tyrosine kinase inhibitors (TKIs). The purpose of this study was to assess the predictive value of monitoring EGFR genomic alterations in circulating tumor DNA (ctDNA) from patients with NSCLC that undergo treatment with the third‐generation EGFR‐TKI osimertinib. Plasma samples of 52 patients harboring the EGFR T790M mutation were obtained pretreatment (Pre), on day 1 of treatment cycle 4 (C4) or cycle 9 (C9), and at diagnosis of disease progression or treatment discontinuation (PD/stop). CtDNA was screened for EGFR‐TKI‐sensitizing mutations, the EGFR T790M mutation, and other genomic alterations using the cobas EGFR Mutation Test v2 (cobas), droplet digital PCR (ddPCR), and targeted deep sequencing. Analysis of the sensitizing—and T790M—EGFR mutant fractions (MFs) was used to determine tumor mutational burden. Both MFs were found to decrease during treatment, whereas rebound of the sensitizing EGFR MF was observed at PD/stop, suggesting that osimertinib targeted both T790M mutation‐positive tumors and tumors with sensitizing EGFR mutations. Significant differences in the response rates and progression‐free survival were observed between the sensitizing EGFR MF‐high and sensitizing EGFR MF‐low groups (cutoff: median) at C4. In conclusion, ctDNA monitoring for sensitizing EGFR mutations at C4 is suitable for predicting the treatment outcomes in NSCLC patients receiving osimertinib (Clinical Trial Registration No.: UMIN000022076).
Abbreviations
- CIs
- confidence intervals
- ctDNA
- circulating tumor DNA
- ddPCR
- droplet digital PCR
- EGFR
- epidermal growth factor receptor
- MFs
- mutant fractions
- NGS
- next‐generation sequencing
- NSCLC
- non‐small cell lung cancer
- ORR
- overall response rate
- OS
- overall survival
- PD
- progressive disease
- PFS
- progression‐free survival
- PR
- partial response
- SD
- stable disease
- TKI
- tyrosine kinase inhibitor
4.
5.
6.
7.
8.
Azusa Ikeda Yoshihiro Watanabe Hikari Kaba Kimihiko Kaneko Toshiyuki Takahashi Saoko Takeshita 《Brain & development》2019,41(4):367-372
Background
Myelin oligodendrocyte glycoprotein antibodies (MOG Abs) are frequently detected in pediatric acquired demyelinating syndrome (ADS), and MOG-Ab-positive ADS differs from multiple sclerosis (MS) and aquaporin-4 (AQP4)-Ab-positive neuromyelitis optica spectrum disorder (NMOSD) in terms of age distribution, therapeutic response, and prognosis.Methods
Based on medical records, we retrospectively evaluated patients with MOG-Ab-positive NMOSD treated in the acute phase who were followed up in the chronic phase at our hospital from January 2011 to December 2017.Results
The patients comprised two boys and two girls aged 3–12 (median, 8) years. Peak MOG-Ab titers were 1:2048 to 1:32768 (median, 1:10240), and the relapse rate ranged from 0 to 1.25 times/year (median, 0.59 times/year); no sequelae were observed in any cases. Lesions other than those of optic neuritis were distributed at the cortex in one patient, subcortical white matter in four, deep white matter in three, and brainstem in one, all of which were disseminated lesions. No lesions were found in the corpus callosum, periventricular white matter, diencephalon, and regions adjacent to the third and fourth ventricles. The lesions tended to be asymptomatic, and two patients aged >5?years had well-demarcated lesions.Conclusion
All the patients showed disseminated lesions in the subcortical region to deep white matter, which were different from those found in MS and AQP4-Ab-positive NMOSD and were consistent with the characteristics of brain lesions in MOG-Ab-positive ADS, including other disease types. 相似文献9.
10.
Higuchi Takashi Sugisawa Norihiko Yamamoto Jun Oshiro Hiromichi Han Qinghong Yamamoto Norio Hayashi Katsuhiro Kimura Hiroaki Miwa Shinji Igarashi Kentaro Tan Yuying Kuchipudi Shreya Bouvet Michael Singh Shree Ram Tsuchiya Hiroyuki Hoffman Robert M. 《Cancer chemotherapy and pharmacology》2020,85(2):285-291
Cancer Chemotherapy and Pharmacology - Cancers are methionine (MET) and methylation addicted, causing them to be highly sensitive to MET restriction. The present study determined the efficacy of... 相似文献